RELATED ARTICLE
Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation
, , , and
JAMA. ;299():1800-1812.
FULL TEXT
RELATED LETTERS
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():900-900.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
JAMA. ;300():900-901.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
JAMA. ;300():901-901.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
JAMA. ;300():901-901.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
, , and
JAMA. ;300():901-902.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
JAMA. ;300():902-902.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
JAMA. ;300():903-903.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():903-904.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
and
JAMA. ;300():904-904.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():904-904.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
, , and
JAMA. ;300():904-905.
FULL TEXT
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies--Reply
and
JAMA. ;300():905-906.
FULL TEXT